M.R. Jirousek

1.7k total citations
18 papers, 1.4k citations indexed

About

M.R. Jirousek is a scholar working on Molecular Biology, Ophthalmology and Organic Chemistry. According to data from OpenAlex, M.R. Jirousek has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Ophthalmology and 4 papers in Organic Chemistry. Recurrent topics in M.R. Jirousek's work include Retinal Diseases and Treatments (5 papers), Liquid Crystal Research Advancements (4 papers) and Retinal Development and Disorders (3 papers). M.R. Jirousek is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Liquid Crystal Research Advancements (4 papers) and Retinal Development and Disorders (3 papers). M.R. Jirousek collaborates with scholars based in United States, Australia and South Sudan. M.R. Jirousek's co-authors include Hideki Ishii, George L. King, Daisuke Koya, Koji Kuboki, G.S. Robinson, Pu Xia, Zhen Jiang, Lloyd Paul Aiello, William Newsome and Hitoshi Takagi and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

M.R. Jirousek

17 papers receiving 1.3k citations

Peers

Countries citing papers authored by M.R. Jirousek

Since Specialization

Citations

This map shows the geographic impact of M.R. Jirousek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Jirousek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Jirousek more than expected).

Fields of papers citing papers by M.R. Jirousek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. Jirousek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Jirousek. The network helps show where M.R. Jirousek may publish in the future.

Co-authorship network of co-authors of M.R. Jirousek

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. Jirousek. A scholar is included among the top collaborators of M.R. Jirousek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. Jirousek. M.R. Jirousek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	CAT-1004, an oral agent targeting NF-κB in development for treatment of Duchenne muscular dystrophy: Phase 1/2 study design 2015 ·Neuromuscular Disorders ·J. Donovan, H. Lee Sweeney, Krista Vandenborne, Barry S. Russman, M.R. Jirousek, Richard S. Finkel	1
2	G.P.101 2014 ·Neuromuscular Disorders ·Jill C. Milne, J. Donovan, (unknown), Margaret M. Sleeper, David W. Hammers, M.R. Jirousek, Michael J. Curtis	3
3	Treatment of zucker diabetic fatty rats with antisense oligonucleotide to phosphotyrosine phosphatase-1B for 5 weeks halts development of diabetes 2001 ·Eugene N. Bush, Robin Shapiro, Jill E. Clampit, (unknown), Adriana Mika, Peter Jacobson, James M. Trevillyan, M.R. Jirousek, Bradley A. Zinker	4
4	The protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells. 2000 ·PubMed ·Eric D. Slosberg, (unknown), F Xing, Amy E. Ikui, M.R. Jirousek, I. Bernard Weinstein	26
5	Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. 1998 ·PubMed ·Ronald P. Danis, David P. Bingaman, M.R. Jirousek, (unknown)	129
6	Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. 1998 ·Diabetes ·Renu A. Kowluru, M.R. Jirousek, Lawrence E. Stramm, Nadir R. Farid, Ronald L. Engerman, Timothy S. Kern	94
7	Vascular Endothelial Growth Factor-Induced Retinal Permeability is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform-Selective Inhibitor. 1998 ·Retina ·(unknown), (unknown), Allen C. Clermont, Elia J. Duh, Hiroko Ishii, Chikako Takagi, Fumihiko Mori, Thomas A. Ciulla, Kirk Ways, M.R. Jirousek, (unknown), G L King	6
8	Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. 1997 ·Journal of Clinical Investigation ·Daisuke Koya, M.R. Jirousek, (unknown), Hideki Ishii, Koji Kuboki, George L. King	439
9	Suppression of vascular endothelial growth factor (vegf) induced retinal vascular permeability in vivo using an orally effective pkc-β SELECTIVE INHIBITOR 1997 ·Lloyd Paul Aiello, Allen C. Clermont, Elia J. Duh, (unknown), Thomas A. Ciulla, Chikako Takagi, Fumihiko Mori, M.R. Jirousek, George L. King, Sven Bursell	1
10	Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor 1996 ·American Journal of Ophthalmology ·Hiromi Ishii, M.R. Jirousek, Daisuke Koya, Chikako Takagi, Peng Xia, Allen C. Clermont, (unknown), T. S. Kern, (unknown), (unknown), (unknown), (unknown), (unknown)	7
11	Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. 1996 ·Journal of Clinical Investigation ·Pu Xia, Lloyd Paul Aiello, Hideki Ishii, Zhen Jiang, (unknown), G.S. Robinson, Hitoshi Takagi, William Newsome, M.R. Jirousek, George L. King	468
12	Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway 1995 ·American Journal of Physiology-Endocrinology and Metabolism ·Makoto Kunisaki, Sven–Erik Bursell, Allen C. Clermont, Hideki Ishii, Lawrence M. Ballas, M.R. Jirousek, F. Umeda, H Nawata, George L. King	131
13	The Effect of 2- and 3-Lateral Substituents on the Acid Side of 4,4′-Disubstituted Phenylbenzoates and Phenylthiobenzoates on Mesomorphic Properties 1994 ·Molecular crystals and liquid crystals science technology. Section A, Molecular crystals and liquid crystals ·M. E. Neubert, (unknown), (unknown), (unknown), M.R. Jirousek, (unknown), K.S. Murray, (unknown)	11
14	The Effect of Carbonyl Containing Terminal Chains on Mesomorphic Properties in 4,4′- Disubstituted Phenylbenzoates and Phenylthiobenzoates. 4. Phenylbenzoates Containing A (CH ₂ ) _n CO ₂ R'Group ( n = 0–2) on the Phenolic End 1991 ·Molecular crystals and liquid crystals ·M. E. Neubert, (unknown), M.R. Jirousek, (unknown), (unknown), (unknown), (unknown)	11
15	The Effect of Carbonyl Containing Terminal Chains on Mesomorphic Properties in 4,4′-Disubstituted Phenylbenzoates and Phenylthiobenzoates. 5. Phenylbenzoates Containing a (CH₂)_n0₂CR′ Group (n=1,2) on the Phenolic End 1991 ·Molecular crystals and liquid crystals ·M. E. Neubert, (unknown), (unknown), M.R. Jirousek, (unknown), (unknown)	4
16	The Effect of Carbonyl Containing Substituents in the Terminal Chains on Mesomorphic Properties in Some Aromatic Esters and Thioesters 7. α-Keto Group on the Acid End of Phenylbenzoates and Thiobenzoates 1991 ·Molecular crystals and liquid crystals ·M. E. Neubert, (unknown), (unknown), M.R. Jirousek, (unknown)	6
17	Electrophilic levuglandin E2-protein adducts bind glycine: A model for protein crosslinking 1990 ·Prostaglandins ·M.R. Jirousek, Krishna K. Murthi, Robert G. Salomon	17
18	The Effect of Methyl Group Position in Branched Alkyl Chains on the Thiolic End of 4,4′-Disubstituted Thiophenylbenzoates on Mesomorphic Properties and Some Optically Active Analogs as New Ferroelectric Liquid Crystals 1989 ·Molecular Crystals and Liquid Crystals Incorporating Nonlinear Optics ·Mary E. Neubert, (unknown), (unknown), (unknown), M.R. Jirousek, D. Leonhardt, (unknown), (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact